Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Allergy

Sec. Allergen Immunotherapy

Volume 6 - 2025 | doi: 10.3389/falgy.2025.1652198

Correction: Efficacy of index of reactivity-liquid sublingual immunotherapy in allergic rhinoconjunctivitis: a systematic review and meta-analysis of randomized studies

Provisionally accepted
Danilo  Di BonaDanilo Di Bona1*Andrea  Di BiaseAndrea Di Biase1Giovanni  PaolettiGiovanni Paoletti2Rosanna  VillaniRosanna Villani1Gaetano  ServiddioGaetano Serviddio1Josiane  Cognet-SicéJosiane Cognet-Sicé3Silvia  ScuratiSilvia Scurati3Giorgio  Walter CanonicaGiorgio Walter Canonica2
  • 1University of Foggia, Foggia, Italy
  • 2Humanitas University, Milan, Italy
  • 3Stallergenes Greer, Antony, France

The final, formatted version of the article will be published soon.

Di Bona D, Di Biase A, Paoletti G, Villani R, Serviddio G, Cognet-Sicé J, Scurati S and Canonica GW (2025) Efficacy of index of reactivity-liquid sublingual immunotherapy in allergic rhinoconjunctivitis: a systematic review and meta-analysis of randomized studies. Front. Allergy 6:1597003. doi: 10.3389/falgy.2025.1597003 In section Methods, subsection Data analysis, paragraph 2: the reference for "In cases where standard errors (SEs) were provided, SDs were calculated using the formula: □□□□□□□□=□□□□□□□□√□□□□" was erroneously written as (13). It should be (15) as stated below. "In cases where standard errors (SEs) were provided, SDs were calculated using the formula: □□□□□□□□=□□□□□□□□√□□□□ (15)."In section Results, paragraph 3: the references for "Low heterogeneity was observed (Q = 0.37; df = 25; P = 0.22; I² = 20%) but decreased to 0% after excluding three outlier studies" were erroneously written as (26,29,42). It should be (28,31,44) as stated below. "Low heterogeneity was observed (Q = 0.37; df = 25; P = 0.22; I² = 20%) but decreased to 0% after excluding three outlier studies (28, 31, 44)"

Keywords: Meta-analysis, randomized controlled trial, Rhinitis, allergic, SLIT-liquid, Sublingual immunotherapy, Systematic review

Received: 23 Jun 2025; Accepted: 08 Jul 2025.

Copyright: © 2025 Di Bona, Biase, Paoletti, Villani, Serviddio, Cognet-Sicé, Scurati and Canonica. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Danilo Di Bona, University of Foggia, Foggia, Italy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.